Audit 308679

FY End
2023-09-30
Total Expended
$11.63M
Findings
24
Programs
3
Organization: Medical Teams International (OR)
Year: 2023 Accepted: 2024-06-12
Auditor: Kpmg

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
400629 2023-001 Significant Deficiency - C
400630 2023-001 Significant Deficiency - C
400631 2023-001 Significant Deficiency - C
400632 2023-001 Significant Deficiency - C
400633 2023-001 Significant Deficiency - C
400634 2023-001 Significant Deficiency - C
400635 2023-002 Material Weakness - C
400636 2023-002 Material Weakness - C
400637 2023-002 Material Weakness - C
400638 2023-002 Material Weakness - C
400639 2023-002 Material Weakness - C
400640 2023-002 Material Weakness - C
977071 2023-001 Significant Deficiency - C
977072 2023-001 Significant Deficiency - C
977073 2023-001 Significant Deficiency - C
977074 2023-001 Significant Deficiency - C
977075 2023-001 Significant Deficiency - C
977076 2023-001 Significant Deficiency - C
977077 2023-002 Material Weakness - C
977078 2023-002 Material Weakness - C
977079 2023-002 Material Weakness - C
977080 2023-002 Material Weakness - C
977081 2023-002 Material Weakness - C
977082 2023-002 Material Weakness - C

Programs

Contacts

Name Title Type
MYGWXNWZNL65 Sam Wehbe Auditee
2406089832 Andrea Chung Auditor
No contacts on file

Notes to SEFA

Title: Purpose of the Schedule Accounting Policies: The Schedule includes the federal grant activity of Medical Teams under programs of the federal government for the year ended September 30, 2023. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) on the accrual basis of accounting. De Minimis Rate Used: N Rate Explanation: Medical Teams did not use the 10 percent de minimis indirect cost rate and has elected to use the approved indirect cost rate as allowed under the grant agreement. The accompanying schedule of expenditures of federal awards (the Schedule) is a supplementary schedule to Medical Teams International (Medical Teams) financial statements and is presented for purposes of additional analysis. Because the Schedule presents only a selected portion of the activities of Medical Teams, it is not intended to and does not present the financial position, results of operations, or changes in net assets of Medical Teams.
Title: Reporting Entity Accounting Policies: The Schedule includes the federal grant activity of Medical Teams under programs of the federal government for the year ended September 30, 2023. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) on the accrual basis of accounting. De Minimis Rate Used: N Rate Explanation: Medical Teams did not use the 10 percent de minimis indirect cost rate and has elected to use the approved indirect cost rate as allowed under the grant agreement. The reporting entity is described in note 1 to Medical Teams’ financial statements.
Title: Basis of Accounting Accounting Policies: The Schedule includes the federal grant activity of Medical Teams under programs of the federal government for the year ended September 30, 2023. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) on the accrual basis of accounting. De Minimis Rate Used: N Rate Explanation: Medical Teams did not use the 10 percent de minimis indirect cost rate and has elected to use the approved indirect cost rate as allowed under the grant agreement. The Schedule includes the federal grant activity of Medical Teams under programs of the federal government for the year ended September 30, 2023. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) on the accrual basis of accounting.
Title: Indirect Cost Rate Accounting Policies: The Schedule includes the federal grant activity of Medical Teams under programs of the federal government for the year ended September 30, 2023. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) on the accrual basis of accounting. De Minimis Rate Used: N Rate Explanation: Medical Teams did not use the 10 percent de minimis indirect cost rate and has elected to use the approved indirect cost rate as allowed under the grant agreement. Medical Teams did not use the 10 percent de minimis indirect cost rate and has elected to use the approved indirect cost rate as allowed under the grant agreement.
Title: Federal Financial Assistance Accounting Policies: The Schedule includes the federal grant activity of Medical Teams under programs of the federal government for the year ended September 30, 2023. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) on the accrual basis of accounting. De Minimis Rate Used: N Rate Explanation: Medical Teams did not use the 10 percent de minimis indirect cost rate and has elected to use the approved indirect cost rate as allowed under the grant agreement. Federal financial assistance is defined by the Uniform Guidance as assistance provided by a federal agency, either directly or indirectly, in the form of grants, contracts, cooperative agreements, loans, loan guarantees, property, interest subsidies, insurance, or direct appropriations. Accordingly, nonmonetary federal assistance, including federal surplus property, is included in federal financial assistance, and therefore is reported on the Schedule, if applicable. Federal financial assistance does not include direct federal cash assistance to individuals. Solicited contracts between Medical Teams and the federal government for which the federal government procures tangible goods and services are not considered to be federal financial assistance.
Title: Major Programs Accounting Policies: The Schedule includes the federal grant activity of Medical Teams under programs of the federal government for the year ended September 30, 2023. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance) on the accrual basis of accounting. De Minimis Rate Used: N Rate Explanation: Medical Teams did not use the 10 percent de minimis indirect cost rate and has elected to use the approved indirect cost rate as allowed under the grant agreement. The Uniform Guidance establishes criteria to be used for defining major programs. Major programs for Medical Teams are those programs selected for testing using a risk assessment model, as well as certain minimum expenditure requirements, as outlined in the Uniform Guidance. Programs with similar requirements may be grouped into a cluster for testing purpose.

Finding Details

Under the requirements of 2 CFR section 200.305(9), interest earned in excess of $500 per year on federal cash draws must be annually remitted to the Department of Health and Human Services, Payment Management System. For ALN 19.517, the interest earned in excess of $500 of $279 was not remitted to the Department of Health and Human Services, Payment Management System for fiscal year ended September 30, 2023.
Under the requirements of 2 CFR section 200.305(9), interest earned in excess of $500 per year on federal cash draws must be annually remitted to the Department of Health and Human Services, Payment Management System. For ALN 19.517, the interest earned in excess of $500 of $279 was not remitted to the Department of Health and Human Services, Payment Management System for fiscal year ended September 30, 2023.
Under the requirements of 2 CFR section 200.305(9), interest earned in excess of $500 per year on federal cash draws must be annually remitted to the Department of Health and Human Services, Payment Management System. For ALN 19.517, the interest earned in excess of $500 of $279 was not remitted to the Department of Health and Human Services, Payment Management System for fiscal year ended September 30, 2023.
Under the requirements of 2 CFR section 200.305(9), interest earned in excess of $500 per year on federal cash draws must be annually remitted to the Department of Health and Human Services, Payment Management System. For ALN 19.517, the interest earned in excess of $500 of $279 was not remitted to the Department of Health and Human Services, Payment Management System for fiscal year ended September 30, 2023.
Under the requirements of 2 CFR section 200.305(9), interest earned in excess of $500 per year on federal cash draws must be annually remitted to the Department of Health and Human Services, Payment Management System. For ALN 19.517, the interest earned in excess of $500 of $279 was not remitted to the Department of Health and Human Services, Payment Management System for fiscal year ended September 30, 2023.
Under the requirements of 2 CFR section 200.305(9), interest earned in excess of $500 per year on federal cash draws must be annually remitted to the Department of Health and Human Services, Payment Management System. For ALN 19.517, the interest earned in excess of $500 of $279 was not remitted to the Department of Health and Human Services, Payment Management System for fiscal year ended September 30, 2023.
Under the requirements of 2 CFR 200.305 (b)(3), When the reimbursement method is used, the Federal awarding agency or pass-through entity must make payment within 30 calendar days after receipt of the billing, unless the Federal awarding agency or passthrough entity reasonably believes the request to be improper. For ALN 19.517, all selections tested of payments to subrecipients, MTI did not remit payment with federal funds timely, with time between receipt of subrecipient invoice and MTI payment ranging from 3 to 6 months. Total federal funds passed through to subrecipients is $525,953 of which $169,733 was tested.
Under the requirements of 2 CFR 200.305 (b)(3), When the reimbursement method is used, the Federal awarding agency or pass-through entity must make payment within 30 calendar days after receipt of the billing, unless the Federal awarding agency or passthrough entity reasonably believes the request to be improper. For ALN 19.517, all selections tested of payments to subrecipients, MTI did not remit payment with federal funds timely, with time between receipt of subrecipient invoice and MTI payment ranging from 3 to 6 months. Total federal funds passed through to subrecipients is $525,953 of which $169,733 was tested.
Under the requirements of 2 CFR 200.305 (b)(3), When the reimbursement method is used, the Federal awarding agency or pass-through entity must make payment within 30 calendar days after receipt of the billing, unless the Federal awarding agency or passthrough entity reasonably believes the request to be improper. For ALN 19.517, all selections tested of payments to subrecipients, MTI did not remit payment with federal funds timely, with time between receipt of subrecipient invoice and MTI payment ranging from 3 to 6 months. Total federal funds passed through to subrecipients is $525,953 of which $169,733 was tested.
Under the requirements of 2 CFR 200.305 (b)(3), When the reimbursement method is used, the Federal awarding agency or pass-through entity must make payment within 30 calendar days after receipt of the billing, unless the Federal awarding agency or passthrough entity reasonably believes the request to be improper. For ALN 19.517, all selections tested of payments to subrecipients, MTI did not remit payment with federal funds timely, with time between receipt of subrecipient invoice and MTI payment ranging from 3 to 6 months. Total federal funds passed through to subrecipients is $525,953 of which $169,733 was tested.
Under the requirements of 2 CFR 200.305 (b)(3), When the reimbursement method is used, the Federal awarding agency or pass-through entity must make payment within 30 calendar days after receipt of the billing, unless the Federal awarding agency or passthrough entity reasonably believes the request to be improper. For ALN 19.517, all selections tested of payments to subrecipients, MTI did not remit payment with federal funds timely, with time between receipt of subrecipient invoice and MTI payment ranging from 3 to 6 months. Total federal funds passed through to subrecipients is $525,953 of which $169,733 was tested.
Under the requirements of 2 CFR 200.305 (b)(3), When the reimbursement method is used, the Federal awarding agency or pass-through entity must make payment within 30 calendar days after receipt of the billing, unless the Federal awarding agency or passthrough entity reasonably believes the request to be improper. For ALN 19.517, all selections tested of payments to subrecipients, MTI did not remit payment with federal funds timely, with time between receipt of subrecipient invoice and MTI payment ranging from 3 to 6 months. Total federal funds passed through to subrecipients is $525,953 of which $169,733 was tested.
Under the requirements of 2 CFR section 200.305(9), interest earned in excess of $500 per year on federal cash draws must be annually remitted to the Department of Health and Human Services, Payment Management System. For ALN 19.517, the interest earned in excess of $500 of $279 was not remitted to the Department of Health and Human Services, Payment Management System for fiscal year ended September 30, 2023.
Under the requirements of 2 CFR section 200.305(9), interest earned in excess of $500 per year on federal cash draws must be annually remitted to the Department of Health and Human Services, Payment Management System. For ALN 19.517, the interest earned in excess of $500 of $279 was not remitted to the Department of Health and Human Services, Payment Management System for fiscal year ended September 30, 2023.
Under the requirements of 2 CFR section 200.305(9), interest earned in excess of $500 per year on federal cash draws must be annually remitted to the Department of Health and Human Services, Payment Management System. For ALN 19.517, the interest earned in excess of $500 of $279 was not remitted to the Department of Health and Human Services, Payment Management System for fiscal year ended September 30, 2023.
Under the requirements of 2 CFR section 200.305(9), interest earned in excess of $500 per year on federal cash draws must be annually remitted to the Department of Health and Human Services, Payment Management System. For ALN 19.517, the interest earned in excess of $500 of $279 was not remitted to the Department of Health and Human Services, Payment Management System for fiscal year ended September 30, 2023.
Under the requirements of 2 CFR section 200.305(9), interest earned in excess of $500 per year on federal cash draws must be annually remitted to the Department of Health and Human Services, Payment Management System. For ALN 19.517, the interest earned in excess of $500 of $279 was not remitted to the Department of Health and Human Services, Payment Management System for fiscal year ended September 30, 2023.
Under the requirements of 2 CFR section 200.305(9), interest earned in excess of $500 per year on federal cash draws must be annually remitted to the Department of Health and Human Services, Payment Management System. For ALN 19.517, the interest earned in excess of $500 of $279 was not remitted to the Department of Health and Human Services, Payment Management System for fiscal year ended September 30, 2023.
Under the requirements of 2 CFR 200.305 (b)(3), When the reimbursement method is used, the Federal awarding agency or pass-through entity must make payment within 30 calendar days after receipt of the billing, unless the Federal awarding agency or passthrough entity reasonably believes the request to be improper. For ALN 19.517, all selections tested of payments to subrecipients, MTI did not remit payment with federal funds timely, with time between receipt of subrecipient invoice and MTI payment ranging from 3 to 6 months. Total federal funds passed through to subrecipients is $525,953 of which $169,733 was tested.
Under the requirements of 2 CFR 200.305 (b)(3), When the reimbursement method is used, the Federal awarding agency or pass-through entity must make payment within 30 calendar days after receipt of the billing, unless the Federal awarding agency or passthrough entity reasonably believes the request to be improper. For ALN 19.517, all selections tested of payments to subrecipients, MTI did not remit payment with federal funds timely, with time between receipt of subrecipient invoice and MTI payment ranging from 3 to 6 months. Total federal funds passed through to subrecipients is $525,953 of which $169,733 was tested.
Under the requirements of 2 CFR 200.305 (b)(3), When the reimbursement method is used, the Federal awarding agency or pass-through entity must make payment within 30 calendar days after receipt of the billing, unless the Federal awarding agency or passthrough entity reasonably believes the request to be improper. For ALN 19.517, all selections tested of payments to subrecipients, MTI did not remit payment with federal funds timely, with time between receipt of subrecipient invoice and MTI payment ranging from 3 to 6 months. Total federal funds passed through to subrecipients is $525,953 of which $169,733 was tested.
Under the requirements of 2 CFR 200.305 (b)(3), When the reimbursement method is used, the Federal awarding agency or pass-through entity must make payment within 30 calendar days after receipt of the billing, unless the Federal awarding agency or passthrough entity reasonably believes the request to be improper. For ALN 19.517, all selections tested of payments to subrecipients, MTI did not remit payment with federal funds timely, with time between receipt of subrecipient invoice and MTI payment ranging from 3 to 6 months. Total federal funds passed through to subrecipients is $525,953 of which $169,733 was tested.
Under the requirements of 2 CFR 200.305 (b)(3), When the reimbursement method is used, the Federal awarding agency or pass-through entity must make payment within 30 calendar days after receipt of the billing, unless the Federal awarding agency or passthrough entity reasonably believes the request to be improper. For ALN 19.517, all selections tested of payments to subrecipients, MTI did not remit payment with federal funds timely, with time between receipt of subrecipient invoice and MTI payment ranging from 3 to 6 months. Total federal funds passed through to subrecipients is $525,953 of which $169,733 was tested.
Under the requirements of 2 CFR 200.305 (b)(3), When the reimbursement method is used, the Federal awarding agency or pass-through entity must make payment within 30 calendar days after receipt of the billing, unless the Federal awarding agency or passthrough entity reasonably believes the request to be improper. For ALN 19.517, all selections tested of payments to subrecipients, MTI did not remit payment with federal funds timely, with time between receipt of subrecipient invoice and MTI payment ranging from 3 to 6 months. Total federal funds passed through to subrecipients is $525,953 of which $169,733 was tested.